Chembio, OraSure Update On Efforts To Deliver Ebola POC Tests
This article was originally published in The Gray Sheet
Executive Summary
Chembio Diagnostics officials say its partnership with Integrated Biotherapeutics to combine IBT’s Ebola reagents with Chembio’s DPP technology is expected to yield fruit soon, while OraSure says it will reach key milestones on its prospective Ebola test effort this year.